Churchill Pharmaceuticals launches a new updated website with a fresh design

May 22, 2017

King of Prussia, PA., May 16, 2017 Churchill Pharmaceuticals, a drug development biopharmaceutical company specialized in oral oncology, announced the launch of its new web site

The site includes extensive and updated information to provide a detailed overview of the company, its products under development and ongoing projects. It will also help visitors stay informed with the latest news of the company, their publications and the attending events, specifically featured in the “Media Center” section.

Visitors can now benefit from a contemporary design and a richer online content that is easier to navigate. Moreover, the new website has been created with the user experience firmly in mind, and it has been designed using the latest technology so the site is compatible with today’s browsers and mobile devices without the need for Adobe Flash to view it.

About Churchill Pharmaceuticals

Churchill Pharmaceuticals, LLC is focused on providing a new level of value in cancer care by developing quality orally delivered oncology products with optimized clinical profiles. Our commitment is to responsibly deliver these products to the patients, payers and healthcare communities we serve, and resides within the core of our business strategy. The Churchill approach to innovative therapies; merge medicine with technology and possess the potential to transform oncology drug development.

At Churchill, we focus our effort on cancers that are highly prevalent and need alternative treatments. The most advanced Churchill product is for the treatment of prostate cancer and is in advanced development, with an NDA submission planned for early 2017. This product has the potential to fundamentally change how therapy is undertaken and provided to the community at large as a benefit to patients and the healthcare system, as well as how it is distributed and reimbursed.

Our disruptive new approach holds significant promise as a ‘game-changing’ treatment in increasingly common and important diseases. To accomplish these objectives the Churchill team is applying a new level of thinking and acting, join us!

For more information, please visit